Resistin and Oxidative Stress as Markers of Atherosclerosis in Obstructive Sleep Apnea Atherosclerosis and Resistin in OSA

ISSN: 1875-6387 (Online)
ISSN: 1573-398X (Print)


Volume 10, 4 Issues, 2014


Download PDF Flyer




Current Respiratory Medicine Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Joseph Varon
The University of Texas Health Science Center
Houston, TX
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Resistin and Oxidative Stress as Markers of Atherosclerosis in Obstructive Sleep Apnea Atherosclerosis and Resistin in OSA

Author(s): Radostina Vlaeva Cherneva, Ognian Borisov Georgiev, Daniela Stoichkova Petrova, Dinko Georgiev Valev and Julia Ivanova Petrova

Affiliation: Division of Pulmonary Medicine, Medical University, Sofia; Georgi Sofiiski 1str, Sofia, 1431, Bulgaria.

Abstract

Introduction: Cardiovascular (CV) morbidity is increased in patients with obstructive sleep apnea (OSA). Oxidative stress and adipose tissue dysfunction are thought to be important factorsfor the accelerated atherosclerosis in OSA. The role of the various adipokines is however debated.

Aim: The aim of the study was to check whether resitin may be a link between oxidative stress, adiposity and atherosclerosis in OSA patients.

Methods: The common carotid artery (CCA) intima-media thickness (IMT), was measured by ultrasonography in 34non-diabetic, non hypertensive patients with untreated OSA. Oxidative stress (urinary 8-isoprostane levels) was measured by mass spectrometry (Cayman Chemical, USA). Insulin resistance was assessed by the homeostasis modelassessment for insulin resistance (HOMA-IR). Resistin plasma levels were determined by an ELISA kit.

Results: Urinary 8-isoprostanes, but not resistin were associated with the IMT after adjustment for CV risk factors, including HOMA-IR. Resistin levels increased with the degree of OSA severity, but did not correlate to markers of insulin resistance (HOMA-IR) or atherosclerosis. They were, however, associated with the time of sleep at SaO2<90% but not with the urinary 8-isoprostane levels.

Conclusion: In non-diabetic, non-hypertensive OSA patients, resistin plasma levels do not correlate to markers of adiposity, insulin resistance or oxidative stress. IMT was associated only with the levels of oxidative stress (8-urinary isoprostanes).



Purchase Online Rights and Permissions

  
  



Article Details

Volume: 10
First Page: 1
Page Count: 1
DOI: 10.2174/1573398X10666140723172355
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science